Here is a combined rationale that incorporates the best of each individual rationale:

The time left until the outcome to this question is known is considerable, considering the slow pace of change in the animal disease ecosystem. The current situation suggests that the risk of human-to-human transmission remains low, and the majority of cases reported are isolated events with no significant consequences. However, it's also important to consider the possibility of rapid advances in medical research or global cooperation leading to a novel vaccine or treatment development, which could curb the spread of avian influenza among humans.

Conversely, the virus could continue to evolve and adapt, becoming more contagious or virulent among both birds and humans. This would lead to a larger outbreak, potentially with severe consequences for public health and economic stability. The scenario that results in a Yes outcome could be one where there is a significant increase in reported cases, either due to the virus mutating into a more transmissible form or if there is a large-scale failure in controlling outbreaks.

Ultimately, the likelihood of CDC reporting 10,000 or more H5 avian influenza cases in the United States before January 1, 2026 depends on the interplay between these factors. While the status quo outcome suggests that the spread of avian influenza will continue at a steady pace, there is also a risk of rapid change due to advances in medical research or global cooperation, as well as the possibility of the virus evolving and adapting to become more contagious among humans.

### Probability: 72%